SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,472.33 879.09
( 1.23%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,084.74 42.63
(0.06%)

Nikkei 225

10,559.70 118.10
(1.13%)

Forex

USD-INR

96.67 0.30
(0.31%)

EUR-INR

108.31 -0.02
(-0.02%)

GBP-INR

127.86 0.18
(0.14%)

JPY-INR

0.61 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Transgene Biotek Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

526139

INE773D01018

-1.2142009

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

17.43

EPS(TTM)

Face Value()

Div & Yield %

Back

transgene biotek ltd

Transgene Biotek reports consolidated net loss of Rs 0.39 crore in the June 2026 quarter

Aug 07,2026

Net Loss of Transgene Biotek reported to Rs 0.39 crore in the quarter ended June 2026 as against net loss of Rs 0.43 crore during the previous quarter ended June 2025. Sales rose 20.00% to Rs 0.06 crore in the quarter ended June 2026 as against Rs 0.05 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.06	0.05	20
OPM %	-100.00	-280.00	-
PBDT	-0.35	-0.38	8
PBT	-0.39	-0.43	9
NP	-0.39	-0.43	9

72,472.33 879.09 ( 1.23%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,084.74 42.63 (0.06%)

10,559.70 118.10 (1.13%)

96.67 0.30 (0.31%)

108.31 -0.02 (-0.02%)

127.86 0.18 (0.14%)

0.61 0.00 (0.24%)